Systemic counterregulatory response of angiopoietin‐2 after aflibercept therapy for nAMD: a potential escape mechanism

PURPOSE: To analyse the effect of intravitreal aflibercept injections on systemic angiopoietin‐2 (Ang2) and vascular endothelial growth factor (VEGF)‐A levels in patients with neovascular age‐related macular degeneration (nAMD). METHODS: In a prospective, randomized study, aflibercept (2.0 mg/50 µl)...

Descripción completa

Detalles Bibliográficos
Autores principales: Angermann, Reinhard, Rauchegger, Teresa, Nowosielski, Yvonne, Seifarth, Christof, Egger, Stefan, Kralinger, Martina T., Kieselbach, Gerhard F., Zehetner, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519089/
https://www.ncbi.nlm.nih.gov/pubmed/33326179
http://dx.doi.org/10.1111/aos.14691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519089/
https://www.ncbi.nlm.nih.gov/pubmed/33326179
http://dx.doi.org/10.1111/aos.14691

Ejemplares similares